Abstract
The CuZn superoxide dismutase (SOD1), a member of a group of isoenzymes involved in the scavenger of superoxide anions, is a dimeric carbohydrate free protein, mainly localized in the cytosol. The reactive oxygen species (ROS) are involved in many pathophysiological events correlated with mutagenesis, cancer, degenerative processes and aging. In the first part of this mini-review the well known role of SOD1 and ROS are briefly summarized. Following, a potential novel biological action that SOD1 could exert is described, based on the recent researches demonstrating the secretion of this enzyme in many cellular lines. Moreover, the role of impaired mutant SOD1 secretion, associated with cytoplasmic toxic inclusion, which occurs in familial amyotrophic lateral sclerosis (ALS), is summarized. In addition, a depolarization-dependent release of SOD1 in pituitary GH3 cells and in rat synaptosomes through a calcium and SNARE-dependent mechanism is reported.
[1] D. Harman: “The aging process”, Proc. Natl. Acad. Sci. U.S.A., Vol. 78, (1981), pp. 7124–7128. http://dx.doi.org/10.1073/pnas.78.11.712410.1073/pnas.78.11.7124Search in Google Scholar
[2] W. Droge: “Free radicals in the physiological control of cell function”, Physiol. Rev., Vol. 82, (2002), pp. 47–95. Search in Google Scholar
[3] K.B. Beckman and B.N. Ames: “The free radical theory of aging matures”, Physiol. Rev., Vol. 78, (1998), pp. 547–581. Search in Google Scholar
[4] S.E. Schriner, N.J. Linford, G.M. Martin, P. Treuting, C.E. Ogburn, M Emond, P.E. Coskun, W. Ladiges, N. Wolf, H. Van Remmen, D.C Wallace and P.S. Rabinovitch: “Extension of murine life span by overexpression of catalase targeted to mitochondria”, Science, Vol. 308, (2005), pp. 1909–1911. http://dx.doi.org/10.1126/science.110665310.1126/science.1106653Search in Google Scholar
[5] B. Halliwell and J.M.C. Gutteridge: Free Radicals in Biology and Medicine, 2° Ed., Oxford, UK, Clarendon, 1989. Search in Google Scholar
[6] M.U. Shiloh, J.D. MacMicking, S. Nicholson, J.E. Brause, S. Potter, M. Marino, F. Fang, M. Dinauer and C. Nathan: “Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase”, Immunity, Vol. 10, (1999), pp. 29–38. http://dx.doi.org/10.1016/S1074-7613(00)80004-710.1016/S1074-7613(00)80004-7Search in Google Scholar
[7] A.W. Roberts, C. Kim, L. Zhen, J.B Lowe, R. Kapur, B. Petryniak, A Spaetti, J.D. Pollock, J.B. Borneo, G.B. Bradford, S.J. Atkinson, M.C. Dinauer and D.A Williams: “Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense”, Immunity, Vol. 10, (1999), pp. 183–196. http://dx.doi.org/10.1016/S1074-7613(00)80019-910.1016/S1074-7613(00)80019-9Search in Google Scholar
[8] J.D. Pollock, D.A. Williams, M.A. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doerschuk and M.C. Dinauer: “Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production”, Nat. Genet., Vol. 9, (1995), pp. 202–209. http://dx.doi.org/10.1038/ng0295-20210.1038/ng0295-202Search in Google Scholar
[9] J.M. McCord and I. Fridovich: “Superoxide dismutase: an enzymic function for erythrocuprein (hemocupreine)”, J. Biol. Chem., Vol. 244, (1969), pp. 6049–6055. Search in Google Scholar
[10] R.A. Weisiger and I. Fridovich: “Superoxide dismutase. Organelle specificity”, J. Biol. Chem., Vol. 248, (1973), 3582–3592. Search in Google Scholar
[11] S.L. Marklund: “Human copper-containing superoxide dismutase of high molecular weight”, Proc. Natl. Acad. Sci. U. S. A., Vol. 79, (1982), pp. 7634–7638. http://dx.doi.org/10.1073/pnas.79.24.763410.1073/pnas.79.24.7634Search in Google Scholar
[12] F.J. Yost Jr. and I. Fridovich: “An iron-containing superoxide dismutase from Escherichia coli”, J. Biol. Chem., Vol. 248, (1973), pp. 4905–4908. Search in Google Scholar
[13] H.D. Youn, E.J. Kim, J.H. Roe, Y.C. Hah and S.O. Kang: “A novel nickel-containing superoxide dismutase from Streptomyces spp.”, Biochem. J., Vol. 318, (1996), pp. 889–896. Search in Google Scholar
[14] T. Grune, T. Reinheckel and K.J. Davies: “Degradation of oxidized proteins in mammalian cells”, FASEB J., Vol. 11, (1997), pp. 526–534. Search in Google Scholar
[15] V.J. Thannickal and B.L. Fanburg: “Reactive oxygen species in cell signalling”, Am. J. Physiol. Lung Cell. Mol. Physiol., Vol. 279, (2000), L1005–L1028. Search in Google Scholar
[16] C.K. Mittal and F. Murad: “Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3′,5′-monophosphate formation”, Proc. Natl. Acad. Sci. U. S. A., Vol. 74, (1977), pp. 4360–4364. http://dx.doi.org/10.1073/pnas.74.10.436010.1073/pnas.74.10.4360Search in Google Scholar
[17] A.A. White, K.M. Crawford, C.S. Patt and P.J. Lad: “Activation of soluble guanylate cyclase from rat lung by incubation or by hydrogen peroxide”, J. Biol. Chem., Vol. 251, (1976), pp. 7304–7312. Search in Google Scholar
[18] A.B. Parekh and R. Penner: “Store depletion and calcium influx”, Physiol. Rev., Vol. 77, (1997), pp. 901–930. Search in Google Scholar
[19] H. Acker: “Mechanisms and meaning of cellular oxygen sensing in the organism”, Respir. Physiol., Vol. 95, (1994), pp. 1–10. http://dx.doi.org/10.1016/0034-5687(94)90043-410.1016/0034-5687(94)90043-4Search in Google Scholar
[20] H. Bunn and R.O. Poyton: “Oxygen sensing and molecular adaptation to hypoxia”, Physiol. Rev., Vol. 76, (1996), pp. 839–885. Search in Google Scholar
[21] C.M. Atkins and J.D. Sweatt: “Reactive oxygen species mediate activity-dependent neuron-glia signalling in output fibers of the hippocampus”, J. Neurosci., Vol. 19, (1999), pp. 7241–7248. Search in Google Scholar
[22] B.T. Chen, M.V. Avshalumov and M.E. Rice: “H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release”, J. Neurophysiol., Vol. 85, (2001), pp. 2468–2476. Search in Google Scholar
[23] C. Hidalgo, P. Aracena, G. Sanchez and P. Donoso: “Redox regulation of calcium release in skeletal and cardiac muscle”, Biol. Res., Vol. 35, (2002), pp. 183–193. http://dx.doi.org/10.4067/S0716-9760200200020000910.4067/S0716-97602002000200009Search in Google Scholar
[24] K.K. Griendling, D. Sorescu and M. Ushio-Fukai: “NAD(P)H oxidase: role in cardiovascular biology and disease”, Circ. Res., Vol. 86, (2000), pp. 494–501. Search in Google Scholar
[25] Y.J. Suzuki and G.D. Ford: “Redox regulation of signal transduction in cardiac and smooth muscle”, J. Mol. Cell. Cardiol., Vol. 31, (1999), pp. 345–353. http://dx.doi.org/10.1006/jmcc.1998.087210.1006/jmcc.1998.0872Search in Google Scholar PubMed
[26] L.J. Ignarro and P.J. Kadowitz: “The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation”, Annu. Rev. Pharmacol. Toxicol., Vol. 25, (1985), pp. 171–191. http://dx.doi.org/10.1146/annurev.pa.25.040185.00113110.1146/annurev.pa.25.040185.001131Search in Google Scholar
[27] W.P. Arnold, C.K. Mittal, S. Katsuki and F. Murad: “Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations”, Proc. Natl. Acad. Sci. U. S. A., Vol. 74, (1977), pp. 3203–3207. http://dx.doi.org/10.1073/pnas.74.8.320310.1073/pnas.74.8.3203Search in Google Scholar
[28] M.S. Wolin, T.M. Burke-Wolin and KM. Mohazzab-H: “Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms”, Respir. Physiol., Vol. 115, (1999), pp. 229–328. http://dx.doi.org/10.1016/S0034-5687(99)00023-710.1016/S0034-5687(99)00023-7Search in Google Scholar
[29] A.A. White, K.M. Crawford, C.S. Patt and P.J. Lad: “Activation of soluble guanylate cyclase from rat lung by incubation or by hydrogen peroxide”, J. Biol. Chem., Vol. 251, (1976), pp. 7304–7312. Search in Google Scholar
[30] A.N. Lyle and K.K. Griendling: “Modulation of vascular smooth muscle signaling by reactive oxygen species”, Physiology, Vol. 21, (2006), pp. 269–280. http://dx.doi.org/10.1152/physiol.00004.200610.1152/physiol.00004.2006Search in Google Scholar
[31] Z. Ungvari, M.S. Wolin and A. Csiszar: “Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling?”, Antioxid. Redox Signal., Vol. 8, (2006), pp. 1121–1129. http://dx.doi.org/10.1089/ars.2006.8.112110.1089/ars.2006.8.1121Search in Google Scholar
[32] A.A. Miller, G.R. Drummond and C.G. Sobey: “Reactive oxygen species in the cerebral circulation: are they all bad?”, Antioxid. Redox Signal., Vol. 8, (2006), pp. 1113–1120. http://dx.doi.org/10.1089/ars.2006.8.111310.1089/ars.2006.8.1113Search in Google Scholar
[33] N.S. Chandel and G.R. Budinger: “The cellular basis for diverse responses to oxygen”, Free rad. Biol. Med., Vol. 42, (2007), pp. 165–174. http://dx.doi.org/10.1016/j.freeradbiomed.2006.10.04810.1016/j.freeradbiomed.2006.10.048Search in Google Scholar
[34] J.V. Bannister, W.H. Bannister and G. Rotilio: “Aspects of the structure, function, and applications of superoxide dismutase”, CRC Crit. Rev. Biochem., Vol. 22, (1987), pp. 111–180. Search in Google Scholar
[35] J.M. Delabar, A. Nicole, L. D’Auriol, Y. Jacob, M. Meunier-Rotival, F. Galibert, P.M. Sinet and H. Jerome: “Cloning and sequencing of a rat CuZn superoxide dismutase cDNA. Correlation between CuZn superoxide dismutase mRNA level and enzyme activity in rat and mouse tissues”, Eur. J. Biochem., Vol. 166, (1987), pp. 181–187. http://dx.doi.org/10.1111/j.1432-1033.1987.tb13500.x10.1111/j.1432-1033.1987.tb13500.xSearch in Google Scholar
[36] S.L. Marklund: “Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species”, Biochem. J., Vol. 222, (1984), pp. 649–655. Search in Google Scholar
[37] S.L. Marklund: “Expression of extracellular superoxide dismutase by human cell lines”, Biochem J., Vol. 266, (1990), pp. 213–219. Search in Google Scholar
[38] P. Mondola, T. Annella, M. Santillo and F. Santangelo: “Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts”, Int. J. Biochem. Cell. Biol., Vol. 28, (1996), pp. 677–681. http://dx.doi.org/10.1016/1357-2725(96)00004-010.1016/1357-2725(96)00004-0Search in Google Scholar
[39] P. Mondola, M. Bifulco, R. Seru, T. Annella, M.R. Circolo and M. Santillo: “Presence of CuZn superoxide dismutase in human serum lipoproteins”, FEBS Lett., Vol. 467, (2000), pp. 57–60. http://dx.doi.org/10.1016/S0014-5793(00)01123-610.1016/S0014-5793(00)01123-6Search in Google Scholar
[40] M.S. Brown and J.L. Goldstein: “Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis”, Annu. Rev. Biochem., Vol. 52, (1983), pp.223–261. http://dx.doi.org/10.1146/annurev.bi.52.070183.00125510.1146/annurev.bi.52.070183.001255Search in Google Scholar
[41] S.T. Kunitake, M.R. Jarvis, R.L. Hamilton and J.P. Kane: “Binding of transition metals by lipolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins”, Proc. Natl. Acad. Sci. U. S. A., Vol. 89, (1992), pp. 6993–6997. http://dx.doi.org/10.1073/pnas.89.15.699310.1073/pnas.89.15.6993Search in Google Scholar
[42] P. Mondola, T. Annella, R. Seru, F. Santangelo, S. Iossa, A. Gioielli and M. Santillo: “Secretion and increase of intracellular CuZn superoxide dismutase content in human neuroblastoma SK-N-BE cells subjected to oxidative stress”, Brain Res. Bull., Vol. 45, (1998), pp. 517–520. http://dx.doi.org/10.1016/S0361-9230(97)00438-310.1016/S0361-9230(97)00438-3Search in Google Scholar
[43] V. Cimini, G. Ruggiero, T. Buonomo, R. Seru, S. Sciorio, C. Zanzi, F. Santangelo and P. Mondola: “CuZn-superoxide dismutase in human thymus: immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines”, Histochem. Cell. Biol., Vol. 118, (2002), pp. 163–169. Search in Google Scholar
[44] P. Mondola, G. Ruggiero, R. Seru, S. Damiano, S. Grimaldi, C. Garbi, M. Monda, D. Greco and M. Santillo: “The Cu,Zn superoxide dismutase in neuroblastoma SKN-BE cells is exported by a microvesicles dependent pathway”, Mol. Brain Res., Vol. 110, (2003), pp. 45–51. http://dx.doi.org/10.1016/S0169-328X(02)00583-110.1016/S0169-328X(02)00583-1Search in Google Scholar
[45] M. Santillo, A. Secondo, R. Seru, S. Damiano, C. Garbi, E. Taverna, P. Rosa, S. Giovedi, F. Benfenati and P. Mondola: “Evidence of calcium-and SNARE-dependent release of CuZn Superoxide Dismutase from rat pituitary GH3 cells and synaptosomes in response to depolarization”, J. Neurochem., (2007), Epub, 2 Apr. 2007. Search in Google Scholar
[46] F. Aguado, G. Majo, B. Ruiz-Montasell, J.M. Canals, A. Casanova, J. Marsal and J. Blasi: “Expression of synaptosomal-associated protein SNAP-25 in endocrine anterior pituitary cells”, Eur. J. Cell Biol., Vol. 69, (1996), pp. 351–359. Search in Google Scholar
[47] P. Mondola, M. Santillo, R. Seru, S. Damiano, C. Alvino, G. Ruggiero, P Formisano, G. Terrazzano, A. Secondo and L. Annunziato: “Cu,Zn superoxide dismutase increases intracellular calcium levels via a phospholipase C-protein kinase C pathway in SK-N-BE neuroblastoma cells”, Biochem. Biophys. Res. Commun., Vol. 324, (2004), pp. 887–892. http://dx.doi.org/10.1016/j.bbrc.2004.09.13110.1016/j.bbrc.2004.09.131Search in Google Scholar
[48] P. Mondola, R. Seru, M. Santillo, S. Damiano, M. Bifulco, C. Laezza, P. Formisano, G. Rotilio and M.R. Ciriolo: “Effect of Cu,Zn superoxide dismutase on cholesterol metabolism in human hepatocarcinoma (HepG2) cells”, Biochem. Biophys. Res. Commun., Vol. 295, (2002), pp. 603–609. http://dx.doi.org/10.1016/S0006-291X(02)00720-910.1016/S0006-291X(02)00720-9Search in Google Scholar
[49] M. Wu, H. Lee, R.E. Bellas, S.L. Schauer, M. Arsura, D. Katz, M.J. FitzGerald, T.L. Rothstein, D.H. Sherr and G.E. Sonenshein: “Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells”, EMBO J., Vol. 15, (1996), pp. 4682–4690. Search in Google Scholar
[50] V.J. Thannickal, R.M. Day, S.G. Klinz, M.C. Bastien, J.M. Larios and B.L. Fanburg: “Ras-dependent and-independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1”, FASEB J., Vol. 14, (2000), pp. 1741–1748. http://dx.doi.org/10.1096/fj.99-0878com10.1096/fj.99-0878comSearch in Google Scholar
[51] K. Suzukawa, K. Miura, J. Mitsushita, J. Resau, K. Hirose, R. Crystal and T. Kamata: “Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species”, J. Biol. Chem., Vol. 275, (2000), pp. 13175–13178. http://dx.doi.org/10.1074/jbc.275.18.1317510.1074/jbc.275.18.13175Search in Google Scholar
[52] E. Klann, E.D. Roberson, L.T. Knapp and J.D. Sweatt: “A role for superoxide in protein kinase C activation and induction of long-term potentiation”, J. Biol. Chem., Vol. 273, (1998), pp. 4516–4522. http://dx.doi.org/10.1074/jbc.273.8.451610.1074/jbc.273.8.4516Search in Google Scholar
[53] K.W. Roche, R.J. O’Brien, A.L. Mammen, J. Bernhardt and R.L. Huganir: “Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit”, Neuron, Vol. 16, (1996), pp. 1179–1188. http://dx.doi.org/10.1016/S0896-6273(00)80144-010.1016/S0896-6273(00)80144-0Search in Google Scholar
[54] S.E. Tan, R.J. Wenthold and T.R. Soderling: “Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons”, J. Neurosci., Vol. 14, (1994), pp. 1123–1129. Search in Google Scholar
[55] J.H. Wang and D.P. Feng: “Postsynaptic protein kinase C essential to induction and maintenance of long-term potentiation in the hippocampal CA1 region”, Proc. Natl. Acad. Sci. U. S. A., Vol. 89, (1992), pp. 2576–2580. http://dx.doi.org/10.1073/pnas.89.7.257610.1073/pnas.89.7.2576Search in Google Scholar
[56] L.P. Rowland and N.A. Shneider: “Amyotrophic lateral sclerosis”, N. Engl. J. Med., Vol. 344, (2001), pp. 1688–1700. http://dx.doi.org/10.1056/NEJM20010531344220710.1056/NEJM200105313442207Search in Google Scholar
[57] C. Bendotti and M.T. Carri: “Lessons from models of SOD1-linked familial ALS”, Trends Mol. Med., Vol. 10, (2004), pp. 393–400. http://dx.doi.org/10.1016/j.molmed.2004.06.00910.1016/j.molmed.2004.06.009Search in Google Scholar
[58] L.I. Bruijn, T.M. Miller and D.W. Cleveland: “Unraveling the mechanisms involved in motor neuron degeneration in ALS”, Annu. Rev. Neurosci., Vol. 27, (2004), pp. 723–749. http://dx.doi.org/10.1146/annurev.neuro.27.070203.14424410.1146/annurev.neuro.27.070203.144244Search in Google Scholar
[59] Z. Mourelatos, H. Adler, A. Hirano, H. Donnenfeld, J.O. Gonatas and N.K. Gonatas: “Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies”, Proc. Natl. Acad. Sci. U. S. A., Vol. 87, (1990), pp. 4393–4395. http://dx.doi.org/10.1073/pnas.87.11.439310.1073/pnas.87.11.4393Search in Google Scholar
[60] Z. Mourelatos, N.K. Gonatas, A. Stieber, M.E. Gurney and M.C. Dal Canto: “The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease”, Proc. Natl. Acad. Sci. U. S. A., Vol. 93, (1996), pp. 5472–5477. http://dx.doi.org/10.1073/pnas.93.11.547210.1073/pnas.93.11.5472Search in Google Scholar
[61] Y. Fujita, K. Okamoto, A. Sakurai, N.K. Gonatas and A. Hirano: “Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement”, J. Neurol. Sci., Vol. 174, (2000), pp. 137–140. http://dx.doi.org/10.1016/S0022-510X(00)00265-310.1016/S0022-510X(00)00265-3Search in Google Scholar
[62] M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon and H.X. Deng: “Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation”, Science, Vol. 264, (1994), pp. 1772–1775. http://dx.doi.org/10.1126/science.820925810.1126/science.8209258Search in Google Scholar
[63] A. Stieber, J.O Gonatas and N.K. Gonatas: “Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis”, J. Neurol. Sci., Vol. 177, (2000), pp. 114–123. http://dx.doi.org/10.1016/S0022-510X(00)00351-810.1016/S0022-510X(00)00351-8Search in Google Scholar
[64] S. Tobisawa, Y. Hozumi, S. Arawaka, S. Koyama, M. Wada, M. Nagai, M. Aoki, Y. Itoyama, K. Goto and T. Kato: “Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice”, Biochem. Biophys. Res. Commun., Vol. 303, (2003), pp. 496–503. http://dx.doi.org/10.1016/S0006-291X(03)00353-X10.1016/S0006-291X(03)00353-XSearch in Google Scholar
[65] H. Wootz, I. Hansson, L. Korhonen, U. Napankangas and D. Lindholm: “Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS”, Biochem. Biophys. Res. Commun., Vol. 322, (2004), pp. 281–286. http://dx.doi.org/10.1016/j.bbrc.2004.07.11810.1016/j.bbrc.2004.07.118Search in Google Scholar PubMed
[66] P.A. Doucette, L.J. Whitson, X. Cao, V. Schirf, B. Demeler, J.S. Valentine, J.C. Hansen and P.J. Hart: “Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability”, J. Biol. Chem., Vol. 279, (2004), pp. 54558–54566. http://dx.doi.org/10.1074/jbc.M40974420010.1074/jbc.M409744200Search in Google Scholar PubMed
[67] A. Tiwari and L.J. Hayward: “Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction”, J. Biol. Chem., Vol. 278, (2003), pp. 5984–5992. http://dx.doi.org/10.1074/jbc.M21041920010.1074/jbc.M210419200Search in Google Scholar PubMed
[68] Y. Furukawa and T.V. O’Halloran: “Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo-and reduced form of SOD1, leading to unfolding and oxidative aggregation”, J. Biol. Chem., Vol. 280, (2005), pp. 17266–17274. http://dx.doi.org/10.1074/jbc.M50048220010.1074/jbc.M500482200Search in Google Scholar PubMed
[69] A. Tiwari, Z. Xu and L.J. Hayward: “Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis”, J. Biol. Chem., Vol. 280, (2005), pp. 29771–29779. http://dx.doi.org/10.1074/jbc.M50403920010.1074/jbc.M504039200Search in Google Scholar PubMed
[70] J.D. Atkin, M.A. Farg, B.J. Turner, D and J.A. Tomas: Lysaght, Nunan J, Rembach A, Nagley P, Beart PM, Cheema SS and M.K. Horne: “Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of proteindisulfide isomerase with superoxide dismutase 1”, J. Biol. Chem., Vol. 281, (2006), pp. 30152–30165. http://dx.doi.org/10.1074/jbc.M60339320010.1074/jbc.M603393200Search in Google Scholar PubMed
[71] B.J. Turner, J.D. Atkin, M.A. Farg, D.W. Zang, A. Rembach, E.C. Lopes, J.D. Patch, A.F. Hilland and S.S. Cheema: “Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis”, J. Neurosci., Vol. 25, (2005), pp. 108–117. http://dx.doi.org/10.1523/JNEUROSCI.4253-04.200510.1523/JNEUROSCI.4253-04.2005Search in Google Scholar PubMed PubMed Central
[72] B. De Felice, M. Santillo, R. Seru, S. Damiano, G. Matrone, R.R. Wilson and P. Mondola: “Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase gene expression by CuZn superoxide dismutase in human fibroblasts and HepG2 cells”, Gene Expr., Vol. 12, (2004), pp. 29–38. Search in Google Scholar
© 2007 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.